Filing Details
- Accession Number:
- 0001179110-17-009096
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-15 10:07:25
- Reporting Period:
- 2017-06-14
- Filing Date:
- 2017-06-15
- Accepted Time:
- 2017-06-15 10:07:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1109354 | Bruker Corp | BRKR | Laboratory Analytical Instruments (3826) | 043110160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1142621 | Chris Ingen Van | C/O Bruker Corporation 40 Manning Road Billerica MA 01821 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-06-14 | 10,000 | $19.07 | 14,577 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-06-14 | 6,600 | $19.12 | 21,177 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-06-14 | 3,300 | $24.00 | 24,477 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-14 | 19,900 | $28.03 | 4,577 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-06-14 | 10,000 | $0.00 | 10,000 | $19.07 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-06-14 | 6,600 | $0.00 | 6,600 | $19.12 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-06-14 | 3,300 | $0.00 | 3,300 | $24.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-01-06 | No | 4 | M | Direct | |
| 3,400 | 2025-01-05 | No | 4 | M | Direct | |
| 6,700 | 2026-01-05 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.91 to $28.26, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The options exercised vested in three approximately equal annual installments on the anniversary of the grant date commencing January 6, 2015.
- The options exercised vested in two approximately equal annual installments on January 5, 2016 and 2017. The remaining will vest on January 5, 2018.
- The options exercised vested on January 5, 2017. The remaining options will vest in two approximately equal annual installments on each of January 5, 2018 and 2019.
Billionaire Hedge Funds
